Woodline Partners LP 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 4:33 pm Sale |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 12,500 0.400% |
-27,500 (-68.75%) |
Filing |
| 2023-02-10 4:08 pm Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 40,000 9.700% |
-158,000 (-79.80%) |
Filing |
| 2022-02-11 07:23 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 198,000 8.600% |
198,000 (New Position) |
Filing |